Search

for
Search:

Glossary Baricitinib

medication that inhibits enzymes to treat hair loss

Baricitinib, also known by the brand name Olumiant, is a medication that inhibits Janus kinase (JAK) enzymes, which play a role in the inflammatory process. It is used to treat moderate to severe rheumatoid arthritis and has also been approved for treating severe alopecia areata, an autoimmune condition that causes hair loss.

Related Terms

Learn

1 / 3 results

learn Baricitinib

JAK inhibitor pill used for severe alopecia areata

Can Baricitinib work if my hair loss is from stress or anxiety? Baricitinib is approved for severe alopecia areata in adults, an autoimmune condition. It has not been shown to work for stress-related shedding (telogen effluvium) and carries an FDA boxed warning.
Is it true that Baricitinib can stop hair loss suddenly? Or does it take time? In trials of adults with severe alopecia areata, regrowth on baricitinib built gradually over 36 weeks rather than appearing suddenly. The drug carries an FDA boxed warning, and regrowth is usually lost when it is stopped.
Baricitinib: Can I use it even if I don’t have a medical diagnosis but I have patchy hair loss? Baricitinib is approved only for adults with a diagnosis of severe alopecia areata and carries an FDA boxed warning. Patchy hair loss has many causes, so doctors confirm the diagnosis before prescribing it.
All 4 questions on Baricitinib →

View more "Baricitinib" in learn →

Research

5 / 1000+ results

research Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

184 citations , February 2015 in “EBioMedicine”

This study observed that baricitinib treatment led to significant improvement in a patient's alopecia areata symptoms and suggests further clinical trials to explore its potential as a treatment.

research Two Phase 3 Trials of Baricitinib for Alopecia Areata

148 citations , March 2022 in “The New England Journal of Medicine”

In two phase 3 trials, this study found that oral baricitinib significantly improved hair regrowth compared to placebo in adults with severe alopecia areata after 36 weeks, though longer trials are needed to ascertain its long-term efficacy and safety.

research Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

66 citations , June 2021 in “Journal of The American Academy of Dermatology”

In this phase 2 study, baricitinib at 2 mg and 4 mg doses significantly improved hair regrowth in adults with alopecia areata and ≥50% scalp hair loss compared to placebo, without new safety concerns, although the small sample size limits the results' generalizability.

research Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells

51 citations , October 2019 in “Cells”

This study reported that inhibiting the JAK-STAT pathway with baricitinib restored cellular homeostasis, delayed senescence, and reduced proinflammatory markers in Hutchinson-Gilford progeria syndrome cell models.

research Baricitinib: From Rheumatoid Arthritis to COVID‐19

42 citations , April 2021 in “Journal of clinical pharmacology”

This review discusses baricitinib's applications for various inflammatory disorders and highlights its promising efficacy alongside potential adverse effects, advocating for further research before it becomes a standard treatment.

View more "Baricitinib" in research →

Community Join

4 / 14 results

community What are the odds baricitinib will get a topical otc version for androgenic alopecia?

3 years ago

Baricitinib, approved for alopecia areata, might be considered for treating receding hairlines. The discussion is about the possibility of an over-the-counter topical version for androgenic alopecia.

community Anyone heard of or have experience using baricitinib?

1 upvotes 3 years ago

The conversation is about baricitinib, a medicine that can help with hair loss, and why it isn't more popular or widely discussed. No specific experiences with the treatment were shared.

community An arthritis drug that can be used for Alopecia.

5 upvotes 4 years ago

An arthritis drug, baricitinib, is discussed as a potential treatment for autoimmune alopecia, not androgenetic alopecia. Ritlecitinib is also mentioned as a possible treatment for scarring alopecia.

community Does a minoxidil tester exist? To test if whatever you get is actually minoxidil or some fake?

2 years ago

The conversation discusses the uncertainty of the legitimacy of minoxidil products in the EU market and mentions baricitinib as an approved, but expensive alternative. A method to test for real minoxidil involves mixing it with bleach to see if it turns orange or brown.

View more "Baricitinib" in community →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →